Grand News Network

Diopter Technologies to Present Breakthrough Bioshare Polymer Amniotic Membrane Technology at MedDevice Boston 2025

Innovative Dissolving Device Offers New Treatment Paradigm for Ocular Wounds and Injuries

Cambridge, MA, United States, 1st Oct 2025 – Diopter Technologies, a medical device innovator specializing in ophthalmic solutions, today announced it will present a scientific poster at MedDevice Boston, taking place September 30 – October 1, 2025, at the Boston Convention & Exhibition Center. The presentation will showcase the company’s Bioshare polymer amniotic membrane dissolving device, a novel technology designed to treat ocular wounds and injuries.

The Bioshare device represents a significant advancement in ocular surface repair, utilizing biocompatible polymer technology combined with amniotic membrane properties to promote healing while eliminating the need for surgical removal. The dissolving mechanism offers clinicians and patients a streamlined treatment approach for corneal injuries, chemical burns, surgical wounds, and other ocular surface disorders.

Addressing a Significant Market Opportunity

The global ophthalmic devices market continues to experience robust growth, driven by increasing prevalence of eye injuries, rising surgical volumes, and an aging population. The corneal repair and regeneration segment represents a particularly compelling opportunity, with the global corneal implants and devices market projected to reach several billion dollars within the next decade.

Ocular trauma affects millions of patients annually worldwide, with corneal injuries representing one of the most common forms of eye trauma. In the United States alone, approximately 2.4 million eye injuries occur each year, with many requiring advanced therapeutic interventions. The current standard of care often involves sutures, adhesives, or traditional amniotic membrane grafts that require specialized surgical expertise and follow-up procedures.

“The ophthalmic device market is experiencing unprecedented innovation, particularly in regenerative and biologic solutions,” said Christopher Adams, CEO at Diopter Technologies. “Our Bioshare technology addresses a critical unmet need by combining the proven healing properties of amniotic membrane with advanced polymer science to create a user-friendly, dissolving device that simplifies treatment protocols.”

The dissolving polymer platform eliminates complications associated with retention sutures and reduces the burden of device removal procedures, potentially lowering healthcare costs while improving patient outcomes and comfort.

Innovation at the Intersection of Biologics and Biomaterials

Diopter Technologies’ approach leverages the natural healing properties of amniotic membrane, which has been used in ophthalmology for decades to promote epithelialization, reduce inflammation, and minimize scarring. By integrating this biological material with proprietary dissolving polymer technology, the Bioshare device offers controlled degradation that matches the healing timeline of ocular tissue.

Visit Diopter Technologies at MedDevice Boston

Attendees of MedDevice Boston are invited to view the scientific poster presentation and speak with Diopter Technologies representatives to learn more about the Bioshare technology and its potential applications in treating ocular wounds and injuries.

Event Details:

  • Event: MedDevice Boston 2025
  • Dates: September 30 – October 1, 2025
  • Location: Boston Convention & Exhibition Center, Boston, MA
  • Website: www.medeviceboston.com

About Diopter Technologies

Diopter Technologies is a medical device company dedicated to developing innovative solutions for ophthalmic conditions. The company focuses on creating advanced biomaterial technologies that improve patient outcomes, simplify clinical workflows, and address unmet needs in eye care. Through its commitment to research and development, Diopter Technologies aims to transform the treatment landscape for ocular injuries and diseases.

For more information about Diopter Technologies and the Bioshare polymer amniotic membrane dissolving device, please visit www.diopterlabs.com or contact:

Company Details

Organization: Diopter Technologies

Contact Person: Media Contact

Website: https://diopterlabs.com

Email: Send Email

Contact Number: +16179579858

City: Cambridge

State: MA

Country: United States

Release Id: 01102534747